INTERACTIONS BETWEEN MU-OPIOID AND KAPPA-OPIOID AGONISTS IN THE RAT DRUG DISCRIMINATION PROCEDURE

被引:45
作者
NEGUS, SS
PICKER, MJ
DYKSTRA, LA
机构
[1] UNIV N CAROLINA,CURRICULUM NEUROBIOL,CHAPEL HILL,NC 27599
[2] UNIV N CAROLINA,DEPT PSYCHOL,CHAPEL HILL,NC 27599
[3] UNIV N CAROLINA,DEPT PHARMACOL,CHAPEL HILL,NC 27599
关键词
Bremazocine; Buprenorphine; Drug discrimination; Fentanyl; Morphine; Opioid interactions; Tifluadom; U50,488;
D O I
10.1007/BF02247126
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The present study was designed to explore the nature of the interaction between mu and kappa opioid agonists in the rat drug discrimination procedure. In rats trained to discriminate the kappa agonist U50,488 (5.6 mg/kg) from water, the other kappa agonist bremazocine substituted completely for the U50,488 training stimulus, and the additional kappa agonist tifluadom substituted in three of five of rats tested. In contrast, the mu agonists morphine, fentanyl, and buprenorphine produced primarily vehicle-appropriate responding. When morphine, fentanyl, and buprenorphine were combined with the training dose of U50,488, all three mu agonists reduced U50,488-appropriate responding. In rats trained to discriminate the mu agonist morphine (10.0 mg/kg) from saline, the other mu agonists morphine and buprenorphine all substituted in a dose-dependent manner for the morphine training stimulus, whereas U50,488, bremazocine, and tifluadom produced primarily vehicle-appropriate responding. When combined with the training dose of morphine, bremazocine antagonized morphine's discriminative stimulus effects, whereas U50,488 and tifluadom had no effect. The barbiturate pentobarbital neither substituted for, nor antagonized, the discriminative stimulus effects of either U50,488 or morphine. These results suggest that mu agonists and kappa agonists produce interacting effects in the drug discrimination procedure in rats. © 1990 Springer-Verlag.
引用
收藏
页码:465 / 473
页数:9
相关论文
共 56 条
[1]  
BARRY H, 1974, FED PROC, V33, P1814
[2]   ANTI-NOCICEPTIVE ACTIONS OF MORPHINE AND BUPRENORPHINE GIVEN INTRATHECALLY IN THE CONSCIOUS RAT [J].
BRYANT, RM ;
OLLEY, JE ;
TYERS, MB .
BRITISH JOURNAL OF PHARMACOLOGY, 1983, 78 (04) :659-663
[3]  
CHANG KJ, 1981, FED PROC, V40, P2729
[4]  
COLPAERT FC, 1984, J PHARMACOL EXP THER, V230, P193
[5]   EFFECTS OF TIFLUADOM ON FOOD-CONSUMPTION COMPARED WITH CHLORDIAZEPOXIDE AND KAPPA-AGONISTS IN THE RAT [J].
COOPER, SJ ;
MOORES, WR ;
JACKSON, A ;
BARBER, DJ .
NEUROPHARMACOLOGY, 1985, 24 (09) :877-883
[6]   BREMAZOCINE IS AN AGONIST AT KAPPA-OPIOID RECEPTORS AND AN ANTAGONIST AT MU-OPIOID RECEPTORS IN THE GUINEA-PIG MYENTERIC PLEXUS [J].
CORBETT, AD ;
KOSTERLITZ, HW .
BRITISH JOURNAL OF PHARMACOLOGY, 1986, 89 (01) :245-249
[7]   AGONIST AND ANTAGONIST PROPERTIES OF BUPRENORPHINE, A NEW ANTINOCICEPTIVE AGENT [J].
COWAN, A ;
LEWIS, JW ;
MACFARLANE, IR .
BRITISH JOURNAL OF PHARMACOLOGY, 1977, 60 (04) :537-545
[8]   STUDIES INVIVO WITH ICI-174864 AND [D-PEN2, D-PEN5]ENKEPHALIN [J].
COWAN, A ;
ZHU, XZ ;
PORRECA, F .
NEUROPEPTIDES, 1985, 5 (4-6) :311-314
[9]   DISTINCT SUBTYPES OF THE OPIOID RECEPTOR WITH ALLOSTERIC INTERACTIONS IN BRAIN MEMBRANES [J].
DEMOLIOUMASON, CD ;
BARNARD, EA .
JOURNAL OF NEUROCHEMISTRY, 1986, 46 (04) :1118-1128
[10]  
DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274